Trials / Recruiting
RecruitingNCT06833450
Reliability of IUS in Crohn's Disease
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Transabdominal intestinal ultrasound (IUS) is gaining acceptance as a point-of-care test to objectively assess disease activity in Crohn's disease (CD). In order to incorporate individual parameters in a future definition of transmural healing, and for the consistent application of IUS as a modality to assess treatment outcomes and establish therapeutic targets to ensure comparability between future studies, the inter-observer agreement should be determined for all relevant parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Transabdominal intestinal ultrasound | Transabdominal intestinal ultrasound |
Timeline
- Start date
- 2022-01-19
- Primary completion
- 2026-02-01
- Completion
- 2026-02-01
- First posted
- 2025-02-18
- Last updated
- 2025-02-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06833450. Inclusion in this directory is not an endorsement.